Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The Company maintains two wholly owned subsidiaries: Acadia Pharmaceuticals AB based in Malmo, Sweden and Acadia Pharmaceuticals A/S based in Denmark. The Company is developing a portfolio consisting of four product candidates, including the compound, pimavanserin, which it is developing for three separate neurological and psychiatric indications in collaboration with Biovail Laboratories International SRL (Biovail), a subsidiary of Biovail Corp. The indications are Parkinson's disease psychosis, which is in Phase III development, adjunctive therapy in schizophrenia, and Alzheimer's disease psychosis, for which it is initiating a Phase II feasibility study.

Livzon Group Xinbeijiang Pharmaceutical Manufacturing, Inc. engages in the manufacture of pharmaceutical intermediates, chemical raw materials, and additives. It also involves in research and development, and technical services. The company was founded on March 28, 1993 and is headquartered in Qingyuan, China.

Olon is one of the largest European developers and manufacturers, supplying APIs for the pharmaceutical industry worldwide both, for Generic as well as for contract manufacturing. OLON owns 5 manufacturing sites in northern Italy (Rodano, Settimo Torinese, Garbagnate Milanese, Mulazzano and Dorno) with more than 800 employees while INFA Group, with more than 400 employees, has 2 manufacturing sites in Italy, Labochim and Sifavitor, and 1 in Spain, Derivados Químicos.

Zentiva ks specializes in the development, manufacture and marketing of generic pharmaceutical products. It offers generic drugs, over the counter medicines, dietary supplements, cosmetics and pharmaceutical substances. The company's products cover therapy areas of cardiovascular disease, pain, alimentary, genitourinary tract diseases, inflammations and central nervous system diseases including digestive problems. Zentiva was founded in 1989 and is headquartered in Prague, Czech Republic.

Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.

Up to now, the company has a registered capital of 725 million yuan, total assets of 5.3 billion yuan and net assets of 3.6 billion yuan. The company has more than 2,900 employees, including more than 230 masters.The company has two headquarters in Xinchang and Hangzhou. It has six production sites including the plant in Xinchang for finished medicines, the two API plants in Shangyu and Shangrao, the TCM production site in Bayannaoer, Inner Mongolia, and the medical equipment production base of Shenzhen and Shenyang. Aside from that, the company also owns a breeding base in Yunnan. In Shanghai, the company has established its own research institute i n the Zhangjiang Hi-Tech Park. Joint ventures and collaberated labs have also been founded over the years in the U.S.A., the U.K., Denmark, Isereal, Korea as well as other countries.

Baiyu produces pharmaceutical products. Their products include ginkgolide injection, enoxaparin sodium injection, lansoprazole, anticoagulant drugs, digestive drugs, and others. They provide research and development, wholesale, and retail services.

Part of Zhejiang Jingxin Pharmaceutical Co., Ltd., Shanghai Jingxin Biopharmaceutical Co. Ltd. is a Chinese company located in Shanghai that manufactures and distributes biopharmaceutical materials. The firm was acquired by Zhejiang Jingxin Pharmaceutical Co., Ltd. on August 08, 2011 for $3.75 million.

Jiangsu Enhua Pharmaceutical Co., Ltd. is strategically positioned in the central nervous drug market, mainly engaged in the development, production and sales of central nervous system drugs. It is a company specializing in the market segment of central nervous drugs. The main categories include anesthesia and spirit. Class and Neurology, through years of unremitting efforts in product development, production and service, the company has established a complete series of central nervous system drug products and marketing network, and strive to build an important domestic producer and sales of central nervous system drugs. Business.

Sunshine Lake Pharma Co. Ltd., a subsidiary of Shenzhen Dongyangguang Industry Co., Ltd., is a Chinese company. The firm manufactures and supplies pharmaceutical ingredients and drugs. Wen Jia Li has been the CEO since 2021. On December 23, 2022 Shenzhen Dongyangguang Industry Co., Ltd. acquired Sunshine Lake Pharma Co. Ltd. from YiChang HEC ChangJiang Pharmaceutical Co., Ltd. for $330.99 million.

Chongqing Liangjiang Drug Research and Development Center Co., Ltd., established on 2014-01-20, Business scope includes medical,Western medicine,traditional Chinese medicine,Research on raw materials and preparations;manufacture,Sales:Chemical raw materials(Free of Hazardous Chemicals and Class I Precursor Drugs),Pharmaceutical Intermediates(Does not contain drugs,Hazardous Chemicals);Import and export,Technology Import and Export,Sales:cosmetic,Daily Chemicals,Pre-packaged food(After obtaining the relevant administrative license,Engage in business activities within the scope of the license);[law,prohibited by law,not to engage in business;law,Regulatory,After obtaining relevant approvals and permits,before operating].

Nuokangda Pharmaceutical Technology provides product upgrade and technology development services for pharmaceutical companies. It engages in research and development activities related to pharmaceuticals, accessories, medical equipment and supplies, and other pharmaceutical-related areas

Shanghai Bozhiyan New Drug Research Co., Ltd., established on 2020-10-16, Business scope includes general items:Medical Research and Experimental Development;engaged in medical technology,Technical services in the field of biotechnology,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Manufacturing of Specialty Chemical Products(Free of Hazardous Chemicals);Information Technology Consulting Services;Import and export;Technology Import and Export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license) licensed items:pharmaceutical production;Pharmaceutical commissioned production;Drug Wholesale;Drug import and export.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

BociMed is a company engaged in drug research and development and clinical research. Through the establishment of a standardized service system, it provides high-quality R&D and outsourcing services for drug discovery, preclinical pharmaceutical research and development, clinical I-IV trials and registration.Shanghai Bozhiyan New Drug Technology Co., Ltd. is a high-tech enterprise specializing in drug research and development technical services, Shanghai High-tech Enterprise, Shanghai Credit Creation Enterprise, and Shanghai Small and Medium Enterprise Innovation Undertaking Enterprise. The company started in 2007 and was formerly known as Shanghai Maibo Pharmaceutical Technology Co., Ltd., registered in Jinshan Petrochemical Zone, mainly engaged in raw material sales, drug import registration and regional cooperation development in China. In 2012,

Aurobindo Pharma Ltd. engages in the manufacturing of generic pharmaceuticals and active pharmaceutical ingredients. Its portfolio includes antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterological, anti-allergies, and anti-diabetics. The company was founded by Penaka Venkata Ramprasad Reddy and Kambam Nithyananda Reddy on December 26, 1986 and is headquartered in Hyderabad, India.

Part of Jiangsu Xiansheng Medical Diagnosis Co. Ltd., Jiangsu Simcere Pharmaceutical Co., Ltd. is a Chinese company located in Nanjing that manufactures and sells pharmaceutical products. The firm was founded in 1995.

Part of Sio Gene Therapies, Inc., Axovant Sciences GmbH is a Swiss company located in Basel. The firm operates as a clinical-stage biopharmaceutical company which focuses on the treatment of dementia.

Suzhou Pengxu Pharmaceutical Technology Co., Ltd., established on 2011-07-07, Business scope includes research and development of pharmaceutical intermediates,Sales;API,new medical research;new material technology,biomedical technology,Software technology research and development,consult,Services and Transfers;Chemical product sales(Excluding hazardous chemicals),Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts enterprises to operate or prohibits import and export).(The above related licenses can only be operated after obtaining the license)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Xiansheng Pharmaceutical Co., Ltd., established on 1998-09-10, The scope of business includes the production of new compound drugs or active ingredient drugs(Including raw materials and preparations);New Anticancer Drugs,Production of new cardiovascular and cerebrovascular drugs;Sell ​​self-produced products(Production and operation according to the licensing items approved by the Provincial Food and Drug Administration);road freight transport.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)